Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
出版年份 2016 全文链接
标题
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
作者
关键词
Meta-analysis, Type 2 Diabetes Mellitus, Hypoglycaemic drugs, Insulin, Mortality, Morbidity, Randomised Controlled Trials
出版物
BMC Endocrine Disorders
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-07-08
DOI
10.1186/s12902-016-0120-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2015) Silvio E. Inzucchi et al. DIABETOLOGIA
- How many people inject insulin? UK estimates from 1991 to 2010
- (2014) S. E. Holden et al. DIABETES OBESITY & METABOLISM
- National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations
- (2014) Andrew I. Geller et al. JAMA Internal Medicine
- Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review
- (2013) Rémy Boussageon et al. BMC Medical Research Methodology
- Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- Hypoglycemia, With or Without Insulin Therapy, Is Associated With Increased Mortality Among Hospitalized Patients
- (2012) R. Garg et al. DIABETES CARE
- Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis
- (2012) S.-C. Liu et al. DIABETES OBESITY & METABOLISM
- Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial
- (2012) M. Nauck et al. DIABETIC MEDICINE
- Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial
- (2012) Pablo Aschner et al. LANCET
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials
- (2012) Rémy Boussageon et al. PLOS MEDICINE
- Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes: A randomized 26-week study on glycemic control and hypoglycemia
- (2011) B. Gallwitz et al. DIABETES CARE
- Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
- (2011) K. L. Rensing et al. DIABETES OBESITY & METABOLISM
- The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
- (2011) C. J. Currie et al. DIABETES OBESITY & METABOLISM
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Emergency Hospitalizations for Adverse Drug Events in Older Americans
- (2011) Daniel S. Budnitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial
- (2010) P. Hollander et al. DIABETES OBESITY & METABOLISM
- Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial
- (2010) Michaela Diamant et al. LANCET
- Severe Hypoglycemia and Risks of Vascular Events and Death
- (2010) Sophia Zoungas et al. NEW ENGLAND JOURNAL OF MEDICINE
- One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial
- (2009) M. C. Bunck et al. DIABETES CARE
- Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
- (2009) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
- (2009) J.-M. Gamble et al. DIABETES OBESITY & METABOLISM
- Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes
- (2009) Agnès Hartemann-Heurtier et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Mitogenic action of insulin: friend, foe or ‘frenemy’?
- (2009) B. Draznin DIABETOLOGIA
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus
- (2009) Rachel A. Whitmer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study
- (2008) J-F. Blicklé et al. DIABETES OBESITY & METABOLISM
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search